Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Biome Australia's revenue for the
six
months ended in Dec. 2025 was A$12.40 Mil.
Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was A$21.95 Mil.
Biome Australia's Revenue per Share for the
six
months ended in Dec. 2025 was A$0.06.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.10.
During the past 12 months, the average Revenue per Share Growth Rate of Biome Australia was 37.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 54.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 5 years, Biome Australia's highest 3-Year average Revenue per Share Growth Rate was 54.00% per year. The lowest was 54.00% per year. And the median was 54.00% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Biome Australia Revenue Related Terms
Biome Australia Revenue Historical Data
* Premium members only.
The historical data trend for Biome Australia's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Biome Australia's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biome Australia Revenue vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Biome Australia's Revenue distribution charts can be found below:
* The bar in red indicates where Biome Australia's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$21.95 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biome Australia (ASX:BIO) has a Revenue of A$21.95 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Biome Australia and its competitors.
Is Biome Australia's Revenue too high?
Biome Australia's current Revenue is A$21.95 Mil. Overall, Biome Australia has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Biome Australia's Revenue compare to KHC and GIS?
Biome Australia's Revenue of A$21.95 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Consumer Packaged Goods company?
A good Revenue depends on the Consumer Packaged Goods industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Biome Australia and its competitors. Biome Australia's current Revenue is A$21.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biome Australia stock overvalued right now?
Based on GuruFocus' analysis, Biome Australia (ASX:BIO) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.67, compared to a current price of A$0.28 — trading 58.2% below its estimated fair value. The current Revenue is A$21.95 Mil. Biome Australia's overall GF Score™ is 29/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Biome Australia (ASX:BIO), the current Revenue is A$21.95 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biome Australia (ASX:BIO) Overvalued in 2026?
Based on GuruFocus' analysis, Biome Australia stock appears to be undervalued.
The current stock price of A$0.28 is trading 58.2% below its estimated GF Value™ of A$0.67.
GuruFocus considers Biome Australia to be Possible Value Trap.
Key valuation signals for ASX:BIO:
Revenue: A$21.95 Mil
GF Value™: A$0.67 vs. price of A$0.28 (58.2% below fair value)
No single metric tells the full story. See the ASX:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals vitamins and weight management products and live biotherapeutics. The company has one operating segment: researching, developing, manufacturing and distributing evidence-based products linking the gut and human health. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners.
29GF Score
Get the complete analysis for ASX:BIO
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:BIO has been successfully added to your 
